Библиография

Все о гриппе

• Burk RF, Schaffner W, Koenig MG. Severe influenza virus pneumonia in the pandemic of 1968-1969. Arch Intern Med 1971; 127: 1122-1128.
• Collins SD, Lehman, J. Excess deaths from influenza and pneumonia and from important chronic diseases during epidemic periods, 1918-51. Public Health monographs 1953; 10: 1-21.
• Dolin R. Influenza. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, editors. HarrisonХs principles of internal medicine. USA: Library of Congress 1991; 695-700.
• Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987; 136: 550-555.
• Jones A, Macfarlane J, Pugh S. Antibiotic therapy, clinical features and outcome of 36 adults presenting to hospital with proven influenza: do we follow guidelines? Postgrad Med 1991; 67: 988-990.
• Kaye D, Rosenbluth M, Hook EW, Kilbourne ED. Endemic influenza. II The nature of the disease in the post-pandemic period. Am Rev Respir Dis 1961; 85: 9-21.
• LaForce FM, Nichol KL, Cox NJ. Influenza: virology, epidemiology, disease, and prevention. Am J Prev Med 1994; 10: 31-44.
• Leebeek FWG, Baggen MGA, Mulder LJMM, Dingemans-Dumas AM. Rhabdomyolysis associated with influenza A virus infection. Neth J Med 1995; 46: 189-192.
• Martin CM, Kunin CM, Gottlieb LS, Barnes MW, Liu C, Finland M. Asian influenza A in Boston, 1957-1958. I Observations in thirty-two influenza-associated fatal cases. Arch Intern Med 1959; 103: 515-531.
• Martin CM, Kunin CM, Gottlieb LS, Finland M. Asian influenza A in Boston. II Severe staphylococcal pneumonia complicating influenza. Arch Intern Med 1959; 103: 532-542.
• Middleton PJ, Alexander RM, Szymanski MT. Severe myositis during recovery from influenza. Lancet 1970; 2: 533-535.
• Scheiblauer H, Reinacher M, Tashiro M, Rott R. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J Infect Dis 1992; 166: 783-791.
• Schwarzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127: 1037-1041.
• Simon NM, Rovner RN, Berlin BS. Acute myoglobinuria associated with type A2 (Hong Kong) influenza. JAMA 1970; 212: 1704-1705.
• Sperber SJ, Francis JB. Toxic shock syndrome during an influenza outbreak. JAMA 1987; 257: 1086-1087.
• Stuart-Harris CH. Influenza and its complications - I. British Medical Journal 1966; 1: 149-150.
• Stuart-Harris CH. Influenza and its complications - II. British Medical Journal 1966; 1: 217-8.
• Collard A. La grippe et son histoire. Revue M?dicale de Bruxelles 1974; 30: 61-77.
• de Gooijer AC. In: De Spaanse Griep van Х18. Edited by Philips-Duphar Amsterdam. ISBN 90 6278 7517, 1978; 108-109.
• de Jong JC, Paccaud MF, DeRonde-Verloop FM et al. Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and the Netherlands. Ann Inst Pasteur/Virol 1988; 139: 429-437.
• Dowdle WR. Fort-Dix episode. The 1976 experience. J Infect Dis (Suppl 1) 1997: S69-72.
• Ghendon Y. Introduction to Pandemic Influenza through History. Euro J Epidemiol 1994; 10: 451-453.
• Hannoun C. La grippe. Annales de lХInstitut Pasteur 1995; 6 (1): 30-36.
• Hirsch A. Handbook of geographical and historical pathology. 1. Translated by C Creichton, New Sydenham Society London, 1883.
• Marwick C. Readiness is all: Public Health experts draft plan outlining pandemic influenza response. JAMA 1996; 275: 179-180.
• Noble ER. Epidemiological and clinical aspects of influenza. In: Basic and Applied Influenza Research. Ed. AS Beare. Pub CRC Press Inc. Boca Raton, Florida, 1982.
• Stuart-Harris CH. Virus of the 1968 Influenza pandemic. Nature 1970; 225: 850-851.
• Stuart-Harris CH, Schild GC and Oxford JS. Influenza: the viruses and the disease. Pub Edward Arnold. 1985.
• Taubenberger JK, Reid AH, Krafft AE et al. Initial genetic characterization of the 1918 ФSpanishХ influenza virus. Science 1997; 275: 1793-1796.
• Wells DL, Hopfensperger DJ, Arden NH, Harmon MW, Davis JP, Tipple MA, Schonberger LB. Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA 1991; 265(4): 478-81.
• Claas EC, Jawaoka Y, de Jong JC et al. Infection of Children with Avian-Human Reassortant Influenza virus from pigs in Europe. Virology 1994; 204: 453-457.
• Kurtz J, Manvell RJ and Banks, J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 1996; 348: 901-902.
• Schild G, Robertson J and Wood J. Influenza viruses and vaccines. In: viral and other infections of the human respiratory tract 1. Ed S Myint and D Taylor-Robinson. Pub: Chapman and Hall 1996: 251-274.
• Scholtissek C. Molecular aspects of the epidemiology of virus disease. Experiment 1987; 43: 1197-2001.
• Taubenberger JK, Reid AH, Krafft AE et al. Initial genetic characterization of the 1918 'Spanish' influenza virus. Science 1997; 275: 1793-1796.
• Webster RG, Bean WJ, Gorman TO et al. Evolution and ecology of influenza A viruses. Microbiol 1992; 56: 159-179.
• WHO. Recommended composition of influenza virus vaccines for use in the 1998-1999 season. Weekly Epidemiological Record 1998; 73: 56-63.
• National Vaccine Program Office Pandemic Influenza: A Planning Guide for State and Local
• INFLUENZA Fact Sheet No 211 February 1999 WHO information
• INFLUENZA A(H5N1) Fact Sheet No 188 January 1998
• Centers for Disease Control and Prevention: INFLUENZA
• Orthomyxoviruses Robert B. Couch
• National Foundation for Infectious Diseases: Symptoms
• National Foundation for Infectious Diseases: The Virus Structure
• Myxoviruses
• Frequently asked questions on Flu Public health Laboratory service
• Fleming DM and Cohen JM. Experience of European Collaboration in Influenza surveillance in the winter 1993-1994. J. Public Health Medicine 18, 133-142, 1996.
• Snacken R, Bensadon M,Strauss A. The CARE Telematics Network for the surveillance of influenza in Europe. Methods of Information in Medicine, 1995, 34, 518-22.
• Snacken R, Manuguerra JC, Taylor P. European Influenza Surveillance Scheme on the Internet. Method of Information in Medicine, 1998, 37, 266-270.
• Zambon M. Sentinel Surveillance of influenza in Europe, 1997/1998. Eurosurveillance Vol. 3- no 3 March 1998.
• Zambon M, van der Werf S., Rebelo de Andrade H. European Influenza Surveillance Scheme. Combined clinical and virological surveillance and data exchange through the internet. poster August 1998 Hannover.
• THE WHO INFLUENZA PROGRAMME Fact Sheet No 212 February 1999
• Н.А. Малышев, К.З. Смагулов "Дифференциальная диагностика". Медицина для всех № 3 (14), 1999
• Справочник-путеводитель практикующего врача. Гл. редакторы И.Н.Денисов, Э.Г.Улумбеков. М., "ГЭОТАР Медицина" 1998 г.
• Руководство по медицине. Диагностика и терапия. Гл. редактор Роберт Берклоу. М., "Мир" 1997 г.
• Н.В Медуницын. Вакцинология. М., "Триада-Х", 1999 г.
• Бактерийные, сывороточные и вирусные лечебно-профилактические препараты. Аллергены. Дезинфекционо-стерилизационные режимы поликлиник. Справочник практического врача. под ред. Н.А. Озерецковского, Г.И. Останина. Санкт-Петербург, "Фолиант", 1998 г.
• Р.Я. Мешкова. Иммнопрофилактика. Руководство для врачей. Смоленск, "Русич" 1999 г.
• ГРИПП И ВАКЦИНОПРОФИЛАКТИКА ГРИППА: эпидемиологический и экономический аспекты. Русский Медицинский Журнал, том 6 №22 1998 г.

Лечение

• Belshe RB, Burk B, Newman F, Cerruti RL and Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159: 430-435.
• Dolin R, Reichman RC, Madore HP, Maynard R, Linton PM and Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580-584.
• Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG and Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696-1702.
• Oxford J and Al-Jabri A. Specific antiviral therapy of respiratory viruses. In: viral and other infections of the human respiratory tract 1. Ed. S. Myint and D. Taylor-Robinson. Pub: Chapman and Hall 1996: 397-420.
• WHO. Current status of amantadine and rimantadine as anti-influenza A agents: memorandum from a WHO meeting. Bull WHO 1985; 63: 51-56.
• ANTIVIRAL DRUGS FOR INFLUENZA Centers for Disease Control and Prevention
• Neuraminidase Inhibitors for Treatment of Influenza A and B Infections MMWR Recommendations and Reports December 17, 1999 / 48(RR14);1-9
• В.Ф. УЧАИКИН, член-корреспондент РАМН, профессор, заведующий кафедрой детских инфекций РГМУ, главный детский инфекционист МЗ РФ. При участии О.В. ШАМШЕВОЙ, директора центра вакцинопрофилактики "Диавакс", кандидата медицинских наук. "Как лечить грипп" Медицина для всех № 3 (14), 1999.
• "Инфлюэнца, испанка, или просто грипп" Сестринское дело №6 1997
• Справочник-путеводитель практикующего врача. Гл. редакторы И.Н.Денисов, Э.Г.Улумбеков. М., "ГЭОТАР Медицина" 1998 г.
• Руководство по медицине. Диагностика и терапия. Гл. редактор Роберт Берклоу. М., "Мир" 1997 г.

Профилактика

• "Эффективность иммунопрофилактики гриппа субъединичной вакциной Инфлювак у детей с соматической патологией". Авторы: О.В.Шамшева, В.Ф. Учайкин, Е.И. Бурцева, А.Н. Слепушкин, И.Н. Новикова, Г.А. Ельшина. Российский вестник перинатологии и педиатрии. Том 45, 4'2000
  
• "Иммунизация против гриппа. Часть 1: Проводимая в настоящее время политика вакцинации против гриппа и создание новых вакцин". A.M. Palache, I.A. de Bruijn and J. Nauta. In: Journal of Clinical Research,1999
  
• "Иммунизация против гриппа. Часть 2: 15-летний опыт применения субъединичной гриппозной вакцины". A.M. Palache, I.A. de Bruijn and J. Nauta. In: Journal of Clinical Research,1999
  
• "Сравнение серологии и реактогенности субъединичных вакцин, цельновирионных вакцин и вакцин из разрушенных вирусов. Обзор и мета-анализ литературных данных".
  WEP Beyer, A.M. Palache and A.D.M.E. Osterhaus In: Clinical Drug Investigation, 1998, vol 15(1), pp:1-12.
  
• "Influenza Vaccines: A Reappraisal of Their Use"
  A.M. Palache. In: Drugs, 1997, vol 6, pp 841-856.
  
• "Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. A review and meta-analysis of the literature".
  WEP Beyer, A.M. Palache and A.D.M.E. Osterhaus In: Clinical Drug Investigation, 1998, vol 15(1), pp:1-12.
  
• "Influenza immunisation I: Influenza vaccination policies and new vaccine developments. II: Fifteen years experience with a subunit influenza vaccine". A.M. Palache, I.A. de Bruijn and J. Nauta.
  In: Journal of Clinical Research,1999
  
• "Influenza virus infections in infants".
  W.P. Glezen, L.H. Taber, A.L. Frank, W.C. Gruber and P.A. Piedra In: Pediatr Infect Dis J, 1997, vol 16, pp 1065-1068.
  
• "Factors associated with influenza coverage among elderly: Role of health care personnel".
  P.O. Hokanen, T. Keistinen and S-L Kivela. In: Public Health, 1996, vol 110, pp 163-168.
  
• "Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens".
  K.L. Nichol, J. Wuorenma and T. von Sternberg. In: Archives of Internal Medicine, 1998, vol 158(16), pp 1769-1776
  
• "Annually repeated influenza vaccination in elderly people".
  I.A. de Bruijn. Thesis Leiden University, Leiden, The Netherlands, 1998.
• "Результаты изучения эффективности гриппозной инактивированной субъединичной гриппозной вакцины «Инфлювак»" М.А. Горбунов, Г.А. Ельшина ГИСК им. Л.А. Тарасевича МЗРФ. Международный журнал медицинской практики. №9, 2000 г.
  
• "Эффективность гриппозной вакцины при иммунизации работников здравоохранения. Рандомизированное клиническое испытание" Джеймс А. Уальд, Джулия А. Макмиллан, Джанет Сервинт, Джин Бутта, Мэри Энн О’Риордан, Марк К. Стейнхолф
  JAMA, March 10, 1999 – Vol. 281, No. 10
• "Субъединичная гриппозная вакцина: десятилетний опыт применения"
  A.M. Palache. European Journal of Clinical Research 1992; 3:117–138
  
• "Гриппозные вакцины: обзорное исследование их применения"
  A.M. Palache. In: Drugs, 1997, vol 6, pp 841-856
  
• "Safety, Reactogenicity and Immunogenicity of Madin Darby Canine Kidney Cell-Derived Inactivated Influenza Subunit Vaccine"
  AM Palache, HSJ Scheepers, V de Regt, P van Ewijk, M Baljet, R Brands, GJM van Scharrenburg. In: Inactivated Influenza Vaccines Prepared in Cell Culture. Dev Biol Stand. Basel, Karger, 1999, vol 98, pp 115-125.
  
• "Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination"
  S Spila-Alegiani, S Salmaso, MC Rota, AE Tozzi, R Raschetti.
  In: Vaccine, 1999, vol 17, pp 1898-1904.
  
• "Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)"
  R Glьck In: Vaccine, 1999, vol 17, pp 1782-1787
  
• В стране эпидемия гриппа. Наш аист N 04(48), март 1999 г.
• National Foundation for Infectious Diseases: Vaccination and Treatment
• National Foundation for Infectious Diseases: Who Should Not Get The Vaccination?
• National Foundation for Infectious Diseases: Who Should Get The Vaccination?
• Influenza and Pneumococcal Vaccination Levels Among Adults Aged greater than or equal to 65 Years -- United States MMWR Weekly, October 02, 1998 / 47(38);797-802
• General Recommendations for Preventing Influenza Infection Among Travelers CDC
• Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommendations and Reports April 30, 1999 / 48(RR-04);1-28
• Questions and Answers About Preventing Influenza Infection Among Travelers CDC
  
• VACCINE INFORMATION
• АРБИДОЛ
• Lasky T et al. The Guillian-Barre Syndrome and the 1992-1993 and 1993-1994 influenza vaccines. NEJM 1998, 339, 25:1797-1802.
• Ropper AH, Victor M. Influenza vaccination and the Guillian-Barr? Syndrome. NEJM 1998, 339, 25:1845-6.
• Ghendon Y. Influenza Vaccines: A Main Problem in Control of Pandemics. Euro J Epidemiology 1994; 10: 485-486.
• National Vaccine Program Office Pandemic Influenza: A Planning Guide for State and Local
• "Vaccine Information Statement Influenza (4/14/00) Centers for Disease Control and Prevention National Immunization Program"
• Fleming DM and Cohen JM. Experience of European Collaboration in Influenza surveillance in the winter 1993-1994. J. Public Health Medicine 18, 133-142, 1996.
• Snacken R, Bensadon M,Strauss A. The CARE Telematics Network for the surveillance of influenza in Europe. Methods of Information in Medicine, 1995, 34, 518-22.
• Snacken R, Manuguerra JC, Taylor P. European Influenza Surveillance Scheme on the Internet. Method of Information in Medicine, 1998, 37, 266-270.
• Zambon M. Sentinel Surveillance of influenza in Europe, 1997/1998. Eurosurveillance Vol. 3- no 3 March 1998.
• Zambon M, van der Werf S., Rebelo de Andrade H. European Influenza Surveillance Scheme. Combined clinical and virological surveillance and data exchange through the internet. poster August 1998 Hannover.
• How to Avoid the Flu by Evelyn Zamula November 1994 FDA Consumer.
• THE WHO INFLUENZA PROGRAMME Fact Sheet No 212 February 1999
• Belshe RB, Burk B, Newman F, Cerruti RL and Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159: 430-435.
• Dolin R, Reichman RC, Madore HP, Maynard R, Linton PM and Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307: 580-584.
• Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG and Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989; 321: 1696-1702.
• Oxford J and Al-Jabri A. Specific antiviral therapy of respiratory viruses. In: viral and other infections of the human respiratory tract 1. Ed. S. Myint and D. Taylor-Robinson. Pub: Chapman and Hall 1996: 397-420.
• WHO. Current status of amantadine and rimantadine as anti-influenza A agents: memorandum from a WHO meeting. Bull WHO 1985; 63: 51-56.
• ANTIVIRAL DRUGS FOR INFLUENZA Centers for Disease Control and Prevention
• Н.В Медуницын. Вакцинология. М., "Триада-Х", 1999 г.
• Бактерийные, сывороточные и вирусные лечебно-профилактические препараты. Аллергены. Дезинфекционо-стерилизационные режимы поликлиник. Справочник практического врача. под ред. Н.А. Озерецковского, Г.И. Останина. Санкт-Петербург, "Фолиант", 1998 г.
• Р.Я. Мешкова. Иммнопрофилактика. Руководство для врачей. Смоленск, "Русич" 1999 г.
• ГРИПП И ВАКЦИНОПРОФИЛАКТИКА ГРИППА: эпидемиологический и экономический аспекты. Русский Медицинский Журнал, том 6 №22 1998 г.